Evidence map›Paper›PMID 40942404›Full record

ArticleMaterials (Basel, Switzerland)2025

A Cyclodextrin Polymer for the Removal of Pharmaceuticals as Environmental Pollutants from Water, as Illustrated by the Example of Methylene Blue as a Model Compound.

Iwona Zawierucha, Jakub Lagiewka, Paulina Kapusniak, Damian Kulawik, Sandra Zarska, Tomasz Girek, Aleksandra Ciesielska, Malgorzata Girek-Bak, Wojciech Ciesielski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Iwona ZawieruchaInstitute of Chemistry, Jan Dlugosz University in Czestochowa, Armii Krajowej 13/15, 42-200 Czestochowa, Poland.ORCID 0000-0002-2975-1911
Jakub LagiewkaInstitute of Chemistry, Jan Dlugosz University in Czestochowa, Armii Krajowej 13/15, 42-200 Czestochowa, Poland.ORCID 0000-0003-3706-9485
Paulina KapusniakInstitute of Chemistry, Jan Dlugosz University in Czestochowa, Armii Krajowej 13/15, 42-200 Czestochowa, Poland.ORCID 0000-0002-9980-8020
Damian KulawikInstitute of Chemistry, Jan Dlugosz University in Czestochowa, Armii Krajowej 13/15, 42-200 Czestochowa, Poland.ORCID 0000-0001-6542-0303
Sandra ZarskaInstitute of Chemistry, Jan Dlugosz University in Czestochowa, Armii Krajowej 13/15, 42-200 Czestochowa, Poland.ORCID 0000-0002-6856-5900
Tomasz GirekInstitute of Chemistry, Jan Dlugosz University in Czestochowa, Armii Krajowej 13/15, 42-200 Czestochowa, Poland.ORCID 0000-0001-6647-7168
Aleksandra CiesielskaDepartment of Bioinorganic Chemistry, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdansk, Poland.ORCID 0000-0002-0268-4210
Malgorzata Girek-BakInstitute of Chemistry, Jan Dlugosz University in Czestochowa, Armii Krajowej 13/15, 42-200 Czestochowa, Poland.
Wojciech CiesielskiInstitute of Chemistry, Jan Dlugosz University in Czestochowa, Armii Krajowej 13/15, 42-200 Czestochowa, Poland.ORCID 0000-0001-6844-348X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study developed a beta-cyclodextrin polymer crosslinked with citric acid (CDCAPol) for removing water contaminants using methylene blue (MB) as a model compound. The polymer, which features free carboxyl groups and cyclodextrin cavities, demonstrated high adsorptive capacity. Under optimal conditions (0.01 g adsorbent, pH 6, and 50 mg/dm

Indexed as

cyclodextrin polymerenvironmental pollutantsmethylene bluepharmaceuticalswastewater treatment

Identifiers

PMID40942404
PMCPMC12429037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.